SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Ravn Fischer Annica)
 

Sökning: WFRF:(Ravn Fischer Annica) > (2015) > Determinants of pre...

Determinants of pre-hospital pharmacological intervention and its association with outcome in acute myocardial infarction

Strandmark, Rasmus (författare)
Sahlgrenska University Hospital, Sweden
Herlitz, Johan (författare)
Högskolan i Borås,Akademin för vård, arbetsliv och välfärd,PreHopsen,Sahlgrenska University Hospital, Sweden;University of Borås, Sweden
Axelsson, Christer (författare)
Högskolan i Borås,Akademin för vård, arbetsliv och välfärd,PreHospen,University of Borås, Sweden
visa fler...
Claesson, Andreas (författare)
Karolinska Institutet, Sweden
Bremer, Anders, 1957- (författare)
Högskolan i Borås,Akademin för vård, arbetsliv och välfärd,PreHospen - Centrum för prehospital forskning,University of Borås, Sweden
Karlsson, Thomas, 1956 (författare)
Gothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för samhällsmedicin och folkhälsa, enheten för arbets-och miljömedicin,Institutionen för medicin, avdelningen för samhällsmedicin och folkhälsa, enheten för hälsometri,Institute of Medicine, Department of Public Health and Community Medicine, Section of Occupational and environmental medicine,Institute of Medicine, Department of Public Health and Community Medicine, Health Metrics,University of Gothenburg, Sweden
Jimenez-Herrera, Maria (författare)
Universitat Rovira i Virgili, Spain
Ravn-Fischer, Annica, 1974 (författare)
Sahlgrenska University Hospital, Sweden
visa färre...
 (creator_code:org_t)
2015-12-01
2015
Engelska.
Ingår i: Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine. - : Springer Science and Business Media LLC. - 1757-7241. ; 23:105
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Background: The aim of this study was a) To identify predictors of the use of aspirin in the pre-hospital setting in acute myocardial infarction (AMI) and b) To analyze whether the use of any of the recommended medications was associated with outcome.Methods: All patients with a final diagnosis of AMI, transported by the Emergency Medical Services (EMS) and admitted to the coronary care unit at Sahlgrenska University Hospital in Gothenburg, Sweden, in 2009–2011, were included.Results: 1,726 patients were included. 58 % received aspirin by the EMS. Ischemic heart disease (IHD) was suspected in 84 %. Among patients who did not receive aspirin IHD was still suspected in 67 %. Among patients in whom IHD was suspected, and who were not on chronic treatment with aspirin the following predicted its pre-hospital use: a) age (odds ratio 0.98; 95 % confidence interval (CI) 0.96–0.99); b) a history of myocardial infarction (2.21; 1.21–4.04); c) priority given by EMS (8.07; 5.42–12.02); d) ST-elevation on ECG on admission to hospital (2.22; 1.50–3.29); e) oxygen saturation > 90 % (3.37; 1.81–6.27). After adjusting for confounders among patients who were not on chronic aspirin, only nitroglycerin of the recommended medications was associated with a reduced risk of death within 1 year (hazard ratio 0.40; 95 % CI 0.23–0.70).Conclusions: Less than six out of ten patients with AMI received pre-hospital aspirin. Five clinical factors were independently associated with the pre-hospital administration of aspirin. This suggests that the decision to treat is multifactorial, and it highlights the lack of accurate diagnostic tools in the pre-hospital environment. Nitroglycerin was independently associated with a reduced risk of death, suggesting that we select the use for a low-risk cohort.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Nyckelord

Chest pain
Myocardial infarction
Emergency medical services
Early medical intervention
Aspirin
Nitroglycerin
Medicin
Medicine
Människan i vården

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy